Aceragen Long Term Debt

Aceragen (ACGN) currently reports a long-term debt of $330K as of December 2022. That compares with $550K in the prior-year period — down 40.6% year over year. Use the charts on this page to explore Aceragen's long-term debt history and peer comparisons.

Aceragen's long-term debt decreased from $550K to $330K — a 40.6% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aceragen reported $330K in long-term debt as of December 2022. That compares with $550K in the prior-year period — down 40.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $330K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aceragen, and consider following ACGN for alerts when major investors trade the stock.

Aceragen is classified in the Healthcare sector. On long-term debt, it currently shows $330K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACGN with unrelated industries.